We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Editas Medicine
EDIT
$432M
| $1.01M | 0.01% |
31,500
-600
| -2% | -$19.4K |
|
777
Keysight
KEYS
$57.3B
| $1.01M | 0.01% |
14,737
+761
| +5% | +$47.2K |
|
778
Gartner
IT
$12.2B
| $1M | 0.01% |
6,301
+416
| +7% | +$60.3K |
|
779
Brown-Forman Class B
BF.B
$12.9B
| $1M | 0.01% |
18,092
+863
| +5% | +$44.8K |
|
780
Liberty Global Class A
LBTYA
$3.46B
| $999K | 0.01% |
36,065
+1,845
| +5% | +$51.5K |
|
|
CLR
781
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $988K | 0.01% |
14,496
+3,368
| +30% | +$213K |
|
|
VNE
782
DELISTED
Veoneer, Inc.
VNE
| $983K | 0.01% |
+20,000
| New | +$1.03M |
|
|
MDSO
783
DELISTED
Medidata Solutions, Inc.
MDSO
| $983K | 0.01% |
11,700
-300
| -3% | -$24K |
|
784
Herbalife
HLF
$1.21B
| $972K | 0.01% |
+17,068
| New | +$943K |
|
785
Equifax
EFX
$21.3B
| $967K | 0.01% |
6,660
+550
| +9% | +$71.7K |
|
786
Arch Capital
ACGL
$33.5B
| $963K | 0.01% |
29,573
+1,880
| +7% | +$55.9K |
|
|
SPR
787
DELISTED
Spirit AeroSystems
SPR
| $963K | 0.01% |
10,760
+525
| +5% | +$46.2K |
|
788
CoStar Group
CSGP
$12.8B
| $960K | 0.01% |
19,970
+1,660
| +9% | +$71K |
|
789
Korea Electric Power
KEP
$15.7B
| $957K | 0.01% |
70,556
| – | – |
|
790
CAE Inc. Common Shares
CAE
$8.64B
| $954K | 0.01% |
47,500
+22,500
| +90% | +$460K |
|
791
FirstService
FSV
$6.27B
| $952K | 0.01% |
11,056
| – | – |
|
792
Teladoc Health
TDOC
$1.29B
| $949K | 0.01% |
12,500
+4,000
| +47% | +$285K |
|
|
AERI
793
DELISTED
Aerie Pharmaceuticals
AERI
| $948K | 0.01% |
15,200
-400
| -3% | -$25.7K |
|
|
NLSN
794
DELISTED
Nielsen Holdings plc
NLSN
| $947K | 0.01% |
34,828
+1,636
| +5% | +$44K |
|
795
Avnet
AVT
$7.99B
| $945K | 0.01% |
18,886
+550
| +3% | +$25.2K |
|
796
Vermilion Energy
VET
$1.75B
| $945K | 0.01% |
29,566
+14,000
| +90% | +$468K |
|
797
Pacira BioSciences
PCRX
$974M
| $943K | 0.01% |
20,548
+1,393
| +7% | +$60.2K |
|
798
Medpace
MEDP
$16.8B
| $939K | 0.01% |
16,000
-400
| -2% | -$21.9K |
|
799
Insperity
NSP
$1.96B
| $938K | 0.01% |
+7,900
| New | +$859K |
|
800
Repligen
RGEN
$9.21B
| $936K | 0.01% |
17,200
-400
| -2% | -$20.6K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.